Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1979 Oct;26(1):57–63. doi: 10.1128/iai.26.1.57-63.1979

Chemotaxigenesis by cell surface components of Staphylococcus aureus.

D J Schmeling, P K Peterson, D E Hammerschmidt, Y Kim, J Verhoef, B J Wilkinson, P G Quie
PMCID: PMC414574  PMID: 500215

Abstract

In an attempt to delineate the staphylococcal cell surface components of importance in chemotaxigenesis, we incubated intact Staphylococcus aureus H, crude cell walls, purified cell walls, peptidoglycan, teichoic acid, and cell membranes with human sera. The results reported indicate that both crude cell walls and purified cell walls, as well as peptidoglycan, were potent chemotaxigens. These particles led to the generation in normal human serum of a factor that was chemotactic for human polymorphonuclear leukocytes. Cell wall peptidoglycan and teichoic acid both appeared to play a role in chemotaxigenesis. Kinetic studies employing C2-deficient serum and immunoglobulin-deficient serum revealed that optimal chemotaxigenesis required the presence of an intact classical complement pathway, as well as antibody. Granulocyte aggregometry studies showed that significant levels of C5a were generated in normal serum and that this activated complement component appears to be a major chemotactic factor produced in serum upon interaction with staphylococcal cell wall components.

Full text

PDF
61

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Craddock P. R., Hammerschmidt D., White J. G., Dalmosso A. P., Jacob H. S. Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia. J Clin Invest. 1977 Jul;60(1):260–264. doi: 10.1172/JCI108763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Craddock P. R., White J. G., Jacob H. S. Potentiation of complement (C5a)-induced granulocyte aggregation by cytochalasin B. J Lab Clin Med. 1978 Mar;91(3):490–499. [PubMed] [Google Scholar]
  3. Des Prez R. M., Bryan C. S., Hawiger J., Colley D. G. Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid. Infect Immun. 1975 Jun;11(6):1235–1243. doi: 10.1128/iai.11.6.1235-1243.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fine D. P. Comparison of ethyleneglycoltetraacetic acid and its magnesium salt as reagents for studying alternative complement pathway function. Infect Immun. 1977 Apr;16(1):124–128. doi: 10.1128/iai.16.1.124-128.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Forsgren A., Mclean R. H., Michael A. F., Quie P. G. Studies of the alternate pathway in chelated serum. J Lab Clin Med. 1975 Jun;85(6):904–912. [PubMed] [Google Scholar]
  6. Gallin J. I., Clark R. A., Frank M. M. Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways. Clin Immunol Immunopathol. 1975 Jan;3(3):334–346. doi: 10.1016/0090-1229(75)90020-3. [DOI] [PubMed] [Google Scholar]
  7. Gallin J. I., Durocher J. R., Kaplan A. P. Interaction of leukocyte chemotactic factors with the cell surface. I. Chemotactic factor-induced changes in human granulocyte surface charge. J Clin Invest. 1975 May;55(5):967–974. doi: 10.1172/JCI108026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Grov A., Sveen K. Induction of leukochemotaxis by peptidoglycan of Staphylococcus aureus. Acta Pathol Microbiol Scand B. 1978 Dec;86B(6):375–378. doi: 10.1111/j.1699-0463.1978.tb00059.x. [DOI] [PubMed] [Google Scholar]
  9. Hammerschmidt D. E., Craddock P. R., McCullough F., Kronenberg R. S., Dalmasso A. P., Jacob H. S. Complement activation and pulmonary leukotasis during nylon fiber filtration leukapheresis. Blood. 1978 Apr;51(4):721–730. [PubMed] [Google Scholar]
  10. Harvey R. L., Kronvall G., Troup G. M., Anderson R. E., Williams R. C., Jr Chemotaxis of polymorphonuclear leukocytes by protein A of the staphylococcus. Proc Soc Exp Biol Med. 1970 Nov;135(2):453–456. doi: 10.3181/00379727-135-35073. [DOI] [PubMed] [Google Scholar]
  11. Keller H. U., Hess M. W., Cottier H. The in vitro assessment of leucocyte chemotaxis. Antibiot Chemother (1971) 1974;19:112–125. doi: 10.1159/000395427. [DOI] [PubMed] [Google Scholar]
  12. Kim Y., Friend P. S., Dresner I. G., Yunis E. J., Michael A. F. Inherited deficiency of the second component of complement (C2) with membranoproliferative glomerulonephritis. Am J Med. 1977 May;62(5):765–771. doi: 10.1016/0002-9343(77)90881-6. [DOI] [PubMed] [Google Scholar]
  13. Miller M. E. Pathology of chemotaxis and random mobility. Semin Hematol. 1975 Jan;12(1):59–82. [PubMed] [Google Scholar]
  14. O'Flaherty J. T., Kreutzer D. L., Ward P. A. Chemotactic factor influences on the aggregation, swelling, and foreign surface adhesiveness of human leukocytes. Am J Pathol. 1978 Mar;90(3):537–550. [PMC free article] [PubMed] [Google Scholar]
  15. Peterson P. K., Wilkinson B. J., Kim Y., Schmeling D., Douglas S. D., Quie P. G., Verhoef J. The key role of peptidoglycan in the opsonization of Staphylococcus aureus. J Clin Invest. 1978 Mar;61(3):597–609. doi: 10.1172/JCI108971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Russell R. J., Wilkinson P. C., McInroy R. J., McKay S., McCartney A. C., Arbuthnott J. P. Effects of staphylococcal products on locomotion and chemotaxis of human blood neutrophils and monocytes. J Med Microbiol. 1976 Nov;9(4):433–439. doi: 10.1099/00222615-9-4-433. [DOI] [PubMed] [Google Scholar]
  17. SCHINDLER C. A., SCHUHARDT V. T. LYSOSTAPHIN: A NEW BACTERIOLYTIC AGENT FOR THE STAPHYLOCOCCUS. Proc Natl Acad Sci U S A. 1964 Mar;51:414–421. doi: 10.1073/pnas.51.3.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Snyderman R., Phillips J., Mergenhagen S. E. Polymorphonuclear leukocyte chemotactic activity in rabbit serum and Guinea pig serum treated with immune complexes: evidence for c5a as the major chemotactic factor. Infect Immun. 1970 Jun;1(6):521–525. doi: 10.1128/iai.1.6.521-525.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Snyderman R., Shin H. S., Phillips J. K., Gewurz H., Mergenhagen S. E. A neutrophil chemotatic factor derived from C'5 upon interaction of guinea pig serum with endotoxin. J Immunol. 1969 Sep;103(3):413–422. [PubMed] [Google Scholar]
  20. Stålenheim G., Götze O., Cooper N. R., Sjöquist J., Müller-Eberhard H. J. Consumption of human complement components by complexes of IgG with protein A of Staphylococcus aureus. Immunochemistry. 1973 Aug;10(8):501–507. doi: 10.1016/0019-2791(73)90221-8. [DOI] [PubMed] [Google Scholar]
  21. Wilkinson B. J., Kim Y., Peterson P. K., Quie P. G., Michael A. F. Activation of complement by cell surface components of Staphylococcus aureus. Infect Immun. 1978 May;20(2):388–392. doi: 10.1128/iai.20.2.388-392.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES